NOX-2 Inhibitors may be Potential Drug Candidates for the Managementof COVID-19 Complications

Bimalendu Chowdhury(Roland Institute of Pharmaceutical Sciences), Biswajeet Acharya(Centurion University of Technology and Management), Amulyaratna Behera(Centurion University of Technology and Management), Korikana Hiramani(Roland Institute of Pharmaceutical Sciences), Biswa Mohan Sahoo(Roland Institute of Pharmaceutical Sciences)
Current Drug Research Reviews
July 7, 2023
Cited by 6


Related Papers